Navigation Links
Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
Date:4/2/2008

ent to production and sale of vaccines.

One goal is to complete the registration of IMVAMUNE(R). The vaccine will then be commercialized via sales to the United States and other countries.

In addition, the intention is to build up a biodefense portfolio of projects that can complement IMVAMUNE(R) and ensure the Company a sustained and growing business.

As part of building up this portfolio, Bavarian Nordic has initiated a preclinical program for an anthrax vaccine. The Company sees a number of synergies - both in the development and in market approach which support the development of such a vaccine. Also, it is expected that a combined anthrax and smallpox vaccine can be developed and thus Bavarian Nordic would be able to offer one vaccine against two of the top biological threats. The anthrax program is expected to enter Phase I in 2008.

Cancer

In the short term, the goal is to complete the Phase I/II studies of the vaccine candidate for breast cancer and to initiate Phase I/II studies of the vaccine candidate for prostate cancer.

As and when positive clinical data are obtained, partnering of the projects will be considered and the Company will also keep an eye on potential in-licensing opportunities.

The cancer business area has been given a higher priority and it is the Company's goal to expand the cancer portfolio. Later in 2008 the Company expects to announce initiatives to strengthen this area.

Infectious diseases

The Company has a number of projects in infectious diseases, all of which are at an early development stage: HIV, measles and RSV, dengue fever and Japanese encephalitis. The goal with the first two projects is to complete early-stage clinical trials. If supported by the data obtained, the option of placing these projects in external partnerships will be explored. Alternatively, the Company will seek other external funding. For the latter two projects, discussions with a potential externa
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Vista Partners Updates Coverage; Maintains $3.20 Target Price
3. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
4. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
5. SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials
6. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
7. ImaRx to Report Corporate Updates and 4Q07 Financial Results
8. LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems
9. InfuSystem Holdings Provides Business Update and Comments on Fourth Quarter 2007 Financial Results
10. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
11. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... I.B.I.S., Inc. of Norcoss, Ga., will offer the M...nacom Information Systems in the metro Atlanta a...I.S., Inc. / Inacom Education partnership offers a...ons to technical courses, including Windows Server... Hospital in Stevens Point and Saint Clare,s Hos...
... CHICAGO -- As more organizations look at what ne...ssues, an area that has come under the spotlight i...agement and corporate governance issues have becom...ntenance agreements. , ,The Sarbanes-Oxley Act (SO...etter financial controls on an enterprise,s operat...
... Madison, Wis. - The Douglas Stewart Co., a pro... marketplace, announced a partnership with Mindje...asic 6 and Pro 6 software applications to more tha...in the United States and Canada. , ,The Douglas S...ibutor and marketer of computer products, consumer...
Other Biology Technology:Tech Digest: Inacom; St. Michael's, St. Clare's hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield 2Sarbox necessitating ECM software, but beware of `best practices' 2Sarbox necessitating ECM software, but beware of `best practices' 3
(Date:12/2/2009)...exposed to secondhand cigarette smoke have an incr... even if they never smoked. , Results of this st...ers & Prevention , a journal of the American Assoc...obacco focus in the December issue. , This year ...ed with lung cancer; more than 159,000 will die fr...
(Date:12/2/2009)... results strengthen the evidence that people who s... increased risk for developing colorectal cancer, ...This provides one more reason not to smoke, or to ...ael J. Thun, M.D., M.S., vice president emeritus, ...ican Cancer Society. "Colorectal cancer should be ...
(Date:12/2/2009)...o smoke their first cigarette within minutes after...by-product of nicotine when processed by the body,...umber of cigarettes smoked. , "Since cotinine ...our results suggest that smokers who smoke immedia...ng cancer," said researcher Joshua E. Muscat, Ph.D...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cigarette smoking increases colorectal cancer risk 2Increased nicotine levels detected in those who light-up earlier 2Regence BlueShield of Idaho Announces Executive Changes 53303 1Regence BlueShield of Idaho Announces Executive Changes 53303 2Regence BlueShield of Idaho Announces Executive Changes 53303 3American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 1American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 2American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 3American Association for Homecare Supports Crackdown on Medicare Scammers in Houston Boston New York Louisiana 53300 4Detroit Branch NAACP President Rev Dr Wendell Anthony Denounces Congressman Thaddeus McCotters Resolution 53296 1
...nal Institute of Standards and Technology (NIST), ...y Detection Research Network (EDRN), has validated...se mitochondrial DNA as an early indicator for cer...hat a relatively simple diagnostic test using a DN...f some solid tumors, including lung cancer. , Mito...
... polarity in the developing mammalian embryo is on...biology today. Drs. Davor Solter and Takashi Hiira...sing various techniques, including comprehensive t...lling evidence for the absence of predetermined po...ontrast to those who feel that the site of sperm e...
...re tomorrow (21 July) will outline for the first t...eck and shoulders in vertebrates. The scientists b...ng the skeletal and muscle structure separately th... of ,composite,. This could have significant impli...g of vertebrate evolution. , Scientists at the Wol...
Other Biology News:Scientists discover stem cell origin of neck and shoulders 2
...y™ Technology is designed to create recombin...drin promoter. The expression cassette is transfer...-specific transposition (Tn7) in DH10Bac™ E....ed for transfection and expression in insect cells...
Rabbit Anti-Human F-box hCdc4 (69 kDa isoform) Protein Antibody, Unconjugated from ABR-Affinity BioReagents
GIBCO Earles Balanced Salt Solution (EBSS) (1X); liquid from Invitrogen
Mouse Anti-14-3-3 Tau Monoclonal Antibody, Unconjugated, Clone 3B9 from ABR-Affinity BioReagents
Biology Products: